Journal of Kermanshah University of Medical Sciences
Peer-reviewed Medical Quarterly
Outline
Effect of daily injection of morphine on leishmaniose infection in mice
Authors
Abstract
Background: The aim of this study was to evaluate the effect of chronic injection of morphine on infection with Leishmania major (L. major) in sensitive BALB/c and resistant C57BL/6 mice.
Methods: Morphine injections (2 times /day with 12 hrs intervals, S.c) were begun one week before parasite inoculation. The first group of mice strains was infused with 1.5mg/kg morphine, the second group with 15 mg/kg, and the control received normal saline. After appearance of local reaction on the site of parasite inoculation, the thickness of inoculated paw and countercurrent paw were measured. At the end, all mice were killed and their spleens and popliteal lymph nodes cells were cultured in the presence of Concanavalin-A, and the level of IL-4 was measured.
Results: In C57BL/6, mice local reaction size increased until 5th week and then began to decrease to reach a normal situation. In contrast, in BALB/c mice local reaction continued to increase up to the end of the test, and in some cases led to necrosis. There were no significant differences in local reaction size between tests and controls animals in both strains. In addition, there was not a significant difference at the level of IL-4 in the supernatant between tests and control groups in both two strains.
Conclusion: Chronic injection of morphine didn't have a significant effect on resistance of C57BL/6 and sensitivity of BALB/c mice to infection with L. major, that may result from immune system tolerance to affect of morphine.
References
- 1.The references of this article is available on PDF.
Copyright
© 2011, Journal of Kermanshah University of Medical Sciences. This open-access article is available under the Creative Commons Attribution-NonCommercial 4.0 (CC BY-NC 4.0) International License (https://creativecommons.org/licenses/by-nc/4.0/), which allows for the copying and redistribution of the material only for noncommercial purposes, provided that the original work is properly cited.
Ordering Reprints
Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC
Similar Articles
Application of L-Arginine as nitric oxide inducer and Indomethacin as prostaglandin inhibitor in Balb/c mice infected with Leishmania major MRHO/IR/75/ER
Ghasemi F, Nahrevanian H. Application of L-Arginine as nitric oxide inducer and Indomethacin as prostaglandin inhibitor in Balb/c mice infected with Leishmania major MRHO/IR/75/ER. Ann Mil Health Sci Res. 2013;11(1):e66701. doi:
Apoptotic Effect of Morphine, Imiquimod and Nalmefene on Promastigote, Infected and Uninfected Macrophages with Amastigote of Leishmania Major by Flow Cytometry
Ebrahimisadr P, Ghaffarifar F, Horton J, Dalimi A, Sharifi Z. Apoptotic Effect of Morphine, Imiquimod and Nalmefene on Promastigote, Infected and Uninfected Macrophages with Amastigote of Leishmania Major by Flow Cytometry. Iran J Pharm Res. 2018;17(3):e124787. doi: https://doi.org/10.22037/ijpr.2018.2262
The effect of morphine on phagocytosis of peritoneal phagocytes of mice
Eftekhari R, Shirzad H, Soleimani N, Mirzaei R, Khoshdel A, et al. The effect of morphine on phagocytosis of peritoneal phagocytes of mice. J Kermanshah Univ Med Sci. 2012;16(4):e78781. doi:
In Vivo Assay of Wound Healing Activities of Silymarin Extract on Cutaneous Wounds Caused by Leishmania major
Rastegarian M, Ghanbarinasab Z, Borazjani R, Hosseini M, Aminnia S, et al. In Vivo Assay of Wound Healing Activities of Silymarin Extract on Cutaneous Wounds Caused by Leishmania major. Shiraz E-Med J. 2018;20(3):e79229. doi: https://doi.org/10.5812/semj.79229
In-vitro and In-vivo Antileishmanial Activity of a Compound Derived of Platinum, Oxaliplatin, against Leishmania Major
Ghasemi E, Ghaffarifar F, Dalimi A, Sadraei J. In-vitro and In-vivo Antileishmanial Activity of a Compound Derived of Platinum, Oxaliplatin, against Leishmania Major. Iran J Pharm Res. 2019;18(4):e126267. doi: https://doi.org/10.22037/ijpr.2019.15364.13046
- Scopus by DOI: 0
Last Update: 0 months ago
- Scopus by Title: 0
Last Update: 0 months ago
- Scopus by Title (Ref): 0
Last Update: 0 months ago
- CrossRef: 0
Last Update: 1 day ago